Conditions: Chronic Kidney Disease Renal Insufficiency
Keywords: CKD - Chronic Kidney Disease GBCA - Gadolinium-based contrast agent GFR - Glomerular Filtration Rate MRI - Magnetic Resonance Imaging NSF - Nephrogenic Systemic Fibrosis Known or suspected CKD with an eGFR greater than or equal to 30mL & less than 60 mL/min/1.73m2 as measured within 30 days prior to the OMNISCAN.
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 213
Healthy volunteers: no

Brief summary:
This will be an international, multi-center, post-marketing surveillance study in patients with moderate renal insufficiency who are administered gadodiamide, Omniscan, during a MRI. Omniscan will be administered intravenously at the medical discretion of the prescribing physician.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Omniscan
Intervention descriptions: intervention 1: OMNISCAN will be administered intravenously at the medical discretion of the prescribing physician.

Protocol document: